MiNK Therapeutics, Inc.
INKT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $62,202 | $29,427 | $34,257 | $26,300 |
| - Cash | $14,281,212 | $1,682 | $3,235 | $4,577 |
| + Debt | $0 | $5,506 | $5,118 | $4,925 |
| Enterprise Value | -$14,219,010 | $33,251 | $36,140 | $26,648 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$44 | -$49 | -$51 | -$54 |
| % Margin | – | – | – | – |
| EBITDA | -$2,844 | -$4,189 | -$2,716 | -$2,410 |
| % Margin | – | – | – | – |
| Net Income | -$2,888 | -$4,238 | -$2,767 | -$2,464 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.65 | -1.06 | -0.7 | -0.65 |
| % Growth | 38.7% | -51.4% | -7.7% | – |
| Operating Cash Flow | -$941 | -$1,569 | -$1,340,876 | -$1,728 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$941 | -$1,569 | -$1,340,876 | -$1,728 |